Health Industry News Science

Metagenomics Sequencing Market to 2026 scrutinized in new research including leading industry players

Press Release

The major factor driving the growth of global metagenomics sequencing market is the progressive and dynamic development of faster sequencing techniques and advancements in methods to cope with the exponentially increasing amount of data generated, which are expanding researchers’ capacity to analyze microbial communities from an unlimited variety of habitats and environments. However, the adoption of this approach is hindered by several limitations such as its requirement for parallel advancement in various isolation and identification techniques, more efficient & robust bioinformatics tools, and dearth of highly skilled professionals. Conversely, developing nations offer profitable opportunities for metagenomic sequencing product manufacturers.


Metagenomics is a molecular tool of modern genomics technique, which allows to analyze the DNA without the need for isolation and pure cultivation. In addition, it enables high resolution genomic analysis of unculturable microbes. This tool helps to overcome the major barriers such as uncultivability and low-resolution analysis due to genomic diversity. In addition, it helps in advancement of environmental and clinical microbiology. Owing to falling cost of DNA sequencing, metagenomics now allows in-depth study of microbial ecology than before, and has thus gained immense interest among healthcare professionals and researchers. Prominent players in the global metagenomic sequencing market have opted various strategies such as product launches, approvals, and investment in R&D for advancement in metagenomics sequencing to strengthen their position in the market and sustain the competitive environment.

Download PDF Report Sample with statistical info @


Thermo Fischer Scientific acquired Slovakian mass spec software firm, HighChem on Jun 06, 2019. This acquisition may improvise with better analysis of metagenomic data. Furthermore, on May 28, 2019, precision medical biotechnology company, Macrogen, Inc. received South Korean accreditation of Good Clincal Lab Practices from the country’s Ministry of Food and Drug Safety (MFDS). It has been designated as clinical trial specimen analysis institution. It should benefit Macrogen with improvised clinical diagnostic metagenomics. Furthermore, Brooks Automation, Inc. acquired GENEWIZ group on November 15, 2018, which will improve the company’s global services of metagenomics sequencing.

The global metagenomics sequencing market is segmented on the basis of product & services, technology, application, and region. Based on product & service, the market is classified into instrument, reagents & consumables, and services. The services segment is further segmented into analysis & data interpretation solutions and metagenomic sequencing services. By technology, the market is categorized into shotgun metagenomic sequencing, 16S rRNA sequencing, whole genome sequencing & de novo assembly, and metatranscriptomics. The applications covered in the study include ecological & environmental metagenomics, clinical diagnostic, gut microbe characterization, viral metagenomics, drug discovery, agriculture, and biofuel. Region wise, the market is thoroughly analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Make an Enquiry for Purchase Report @


The report provides a comprehensive analysis of the key players operating in the global metagenomics sequencing market such as Thermo Fisher Scientific Inc., Eurofins Genomics, Agilent Technologies, Inc., Illumina, Inc., Qiagen N.V., Abbot Laboratories, Oxford Nanopore Technologies Ltd., Macrogen, Inc., Enterome SA, and Brooks Automation, Inc. Other players in the value chain are F. Hoffmann-La Roche Ltd., Perkin Elmer, Inc., Pacific Biosciences of California, Inc., Swift Biosciences, Inc., and others.


  • This report encompasses in-depth quantitative analysis of the current trends and future estimations through 2019–2026, which assists to identify the prevailing metagenomics sequencing market opportunities.
  • Key market players are profiled in this report, and their strategies are analyzed thoroughly, which help to understand the competitive outlook of global metagenomics sequence market.
  • Competitive intelligence (of key players in providing services) helps in understanding the competitive scenario across the geographies.
  • Extensive analysis of the market is conducted by following key product positioning and monitoring the top competitors within the market framework.